Timolol maleate 0.25 % Ophthalmic Gel Forming Solution
RxNorm 313407
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 313407 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: timolol maleate 0.25 % Ophthalmic Gel Forming Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Timolol 0.0025 mg/MG Ophthalmic Gel
(Atom ID: 12325708)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely timolol (as timolol maleate) 2.5 mg/1 mL conventional release eye gel (clinical drug)
(Atom ID: 10317807)
PTPrescribable
Designated preferred name (PT):
Timolol (as timolol maleate) 2.5 mg/mL eye gel
(Atom ID: 10321755)
SYPrescribable
Synonym (SY):
Timolol 0.25 % Ophthalmic Gel
(Atom ID: 2989612)
SYPrescribable
Synonym (SY):
Timolol 0.25 % Ophthalmic Gel Forming Solution
(Atom ID: 2989945)
PSNPrescribable
Prescribable Name (PSN):
Timolol maleate 0.25 % Ophthalmic Gel Forming Solution
(Atom ID: 6390918)
Patient Education
Timolol Ophthalmic
Ophthalmic timolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Timolol is in a class of medications called beta-blockers. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.